Engineered Bone Tissue with Naturally-Derived Small Molecules

E-ISSN： 1873-4286|23|24|3585-3594

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.24, 2017-09, pp. : 3585-3594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Osteoinductive Small Molecules: Growth Factor Alternatives for Bone Tissue Engineering

Current Pharmaceutical Design, Vol. 19, Iss. 19, 2013-06 ,pp. : 3420-3428

Bentham Science Publishers

Access to resources Recommend Favorite

Small molecules for bone diseases

By Masuya Keiichi Teno Naoki

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 4, 2010-04 ,pp. : 563-582

Informa Healthcare

Access to resources Recommend Favorite

Naturally Plant-Derived Compounds: Role in Bone Anabolism

Current Molecular Pharmacology, Vol. 5, Iss. 2, 2012-06 ,pp. : 205-218

Bentham Science Publishers

Access to resources Recommend Favorite

Mixture of Fibroblasts and Adipose Tissue-Derived Stem Cells Can Improve Epidermal Morphogenesis of Tissue-Engineered Skin

Cells Tissues Organs, Vol. 195, Iss. 3, 2011-04 ,pp. : 197-206

Karger

Access to resources Recommend Favorite

Regulation of Angiogenesis and Bone Regeneration with Natural and Synthetic Small Molecules

Current Pharmaceutical Design, Vol. 19, Iss. 19, 2013-01 ,pp. : 3403-3419

Bentham Science Publishers

Access to resources Recommend Favorite